Award
National Cancer Institute 5U01CA260369-05
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
Recipient
Philip Abbosh
Award Amount
$422,144.00
Ceiling
$422,144.00
Awarded
August 08, 2025
Identifier
5U01CA260369-05
Research grant awarded by the National Cancer Institute to optimize urinary DNA deep sequencing tests for bladder cancer clinical staging, led by PI Philip Abbosh, with a total award amount of $422,144.
Description
This is a research grant project funded by the National Cancer Institute, focusing on developing urine biopsy tests for bladder cancer staging. The project involves multiple aims including methodology improvements, sample preservation, and clinical validation. The project duration is from August 2021 to July 2027, with a total award amount of $422,144. The primary investigator is Philip Abbosh, and the program officer is Lokesh Agrawal.